Article Information
History
- May 26, 2020.
Article Versions
- You are currently viewing Version 1 of this article (May 26, 2020 - 08:30).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Anna E. Ssentongo, MPH§,1,2,*,
- Paddy Ssentongo, MD, MPH1,3,*,
- Emily S. Heilbrunn, BS1,*,
- Alain Lekoubou, MD, Msc1,4,
- Ping Du, MD, PhD1,
- Duanping Liao, MD, PhD1,
- John S. Oh, MD2 and
- Vernon M. Chinchilli, PhD1
- 1Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania, United States of America
- 2Department of Surgery, Penn State College of Medicine and Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States of America
- 3Center for Neural Engineering, Department of Engineering, Science and Mechanics, The Pennsylvania State University, Pennsylvania, United States of America
- 4Department of Neurology, Penn State College of Medicine and Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States of America
- ↵§
Corresponding Author
Anna Ssentongo, MPH, Penn State University, Department of Surgery, 500 University Drive, Hershey, PA 17033, Pennsylvania State University, USA, Tel: 814-404-5208, Email: assentongo{at}pennstatehealth.psu.edu
↵* Authors contributed equally
Posted May 26, 2020.
Renin-angiotensin-aldosterone system inhibitors and mortality in patients with hypertension hospitalized for COVID-19: a systematic review and meta-analysis
